Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT01758328 · COMPLETED
Trial details
- NCT number
- NCT01758328
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2025-03-17
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.